Antibody therapy for rheumatoid arthritis.

High-quality monoclonal antibodies (mAbs) with specificity for relevant disease molecules can now be produced in abundance. Anti-tumour necrosis factor-alpha therapies have set a new standard for symptom control in rheumatoid arthritis, and blockade of tumour necrosis factor has the potential to pro...

Descripción completa

Detalles Bibliográficos
Autor principal: Taylor, P
Formato: Journal article
Lenguaje:English
Publicado: 2003